XML 37 R26.htm IDEA: XBRL DOCUMENT v3.19.1
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2019
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of Stock-based Compensation Expense for Employees and Non-employees

In the accompanying condensed consolidated statements of operations, the Company recognized stock-based compensation expense for its employees and non-employees as follows:

 

     Three Months Ended
March 31,
 
     2019      2018  

Research and development

   $ 1,184      $ 998  

General and administrative

     515        501  
  

 

 

    

 

 

 

Total stock-based compensation

   $ 1,699      $ 1,499  
  

 

 

    

 

 

 
Schedule of Estimated Grant-date Fair Value of Stock-based Awards Using Black-Scholes Option Pricing Model Assumptions

The estimated grant-date fair values of all of the Company’s stock-based awards were calculated using the Black-Scholes option pricing model, based on assumptions as follows:

 

     Three Months Ended
March 31,
 
     2019     2018  

Expected term (in years)

     5.3 — 6.9       5.4 — 6.9  

Expected volatility

     91 — 94     88 — 91

Risk-free interest rate

     2.5 — 2.6     2.7 — 2.8

Expected dividend rate

     —       —  
Summary of Stock-Based Compensation Activity

A summary of activity under the 2008 Plan, 2015 Plan and 2018 Plan and related information is as follows:

 

           Options Outstanding  
     Shares
Available
for Grant
    Number
of Shares
Outstanding
    Weighted-
Average
Exercise
Price Per
Share
     Weighted-
Average
Remaining
Contractual
Term
(Years)
     Aggregate
Intrinsic
Value of
Outstanding
Options
(in thousands)
 

Outstanding — December 31, 2018

     1,945,025       10,504,412     $ 2.86        7.80      $ 545  

Awards authorized

     2,974,638            

Options granted

     (3,093,300     3,093,300       1.93        

Options exercised

     —         (322,318     1.38        

Options forfeited/cancelled

     77,009       (77,009     5.59        
  

 

 

   

 

 

         

Outstanding — March 31, 2019

     1,903,372       13,198,385     $ 2.66        8.13      $ 1,358  
  

 

 

   

 

 

         

Exercisable — March 31, 2019

       6,571,244     $ 3.09        7.06      $ 1,185  
    

 

 

         

Vested and expected to vest — March 31, 2019

       13,198,385     $ 2.66        8.13      $ 1,358